DPP-4 inhibitors and severe course of illness in patients with COVID-19
- PMID: 33518293
- PMCID: PMC7816885
- DOI: 10.1016/j.therap.2021.01.051
DPP-4 inhibitors and severe course of illness in patients with COVID-19
Comment on
-
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19.Therapie. 2021 Jul-Aug;76(4):361-364. doi: 10.1016/j.therap.2020.12.015. Epub 2020 Dec 26. Therapie. 2021. PMID: 33423787 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
